Cargando…

Quinone oxidoreductase 1 is overexpressed in gastric cancer and associated with outcome of adjuvant chemotherapy and survival

BACKGROUND: Quinine oxidoreductase 1 (NQO1) plays a vital role in protecting normal cells against oxidative damage and electrophilic attack. It is highly expressed in many solid tumors, suggesting a role in cancer development and progression. However, the role of NQO1 in gastric cancer and its effec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Zhi-Nong, Ahmed, Syed Minhaj Uddin, Wang, Qin-Chuan, Shi, Hong-Fei, Tang, Xiu-Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192289/ https://www.ncbi.nlm.nih.gov/pubmed/34168410 http://dx.doi.org/10.3748/wjg.v27.i22.3085

Ejemplares similares

Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study
por: Ren, Deng-Feng, et al.
Publicado: (2018)

TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer
por: Ntavatzikos, Anastasios, et al.
Publicado: (2019)

Development and validation of a novel nomogram for predicting overall survival in gastric cancer based on inflammatory markers
por: Luo, Pan-Quan, et al.
Publicado: (2023)

Role of adjuvant chemotherapy on recurrence and survival in patients with resected ampulla of Vater carcinoma
por: Park, Se Jun, et al.
Publicado: (2023)

Quinone binding site in a type VI sulfide:quinone oxidoreductase
por: Miklovics, Nikolett, et al.
Publicado: (2022)

Adjuvant chemoradiotherapy vs adjuvant chemotherapy in locally advanced Siewert type II/III adenocarcinoma of gastroesophageal junction after D2/R0 resection
por: Kang, Wen-Zhe, et al.
Publicado: (2022)

A new scoring system to evaluate adjuvant chemotherapy for patients with T2N0M0 gastric cancer after D2 gastrectomy
por: Xu, Quan, et al.
Publicado: (2022)

NAD(P)H: Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 Polymorphisms in Papillary Thyroid Microcarcinoma: Correlation with Phenotype
por: Lee, Junguee, et al.
Publicado: (2013)

Impact of duration of adjuvant chemotherapy in radically resected patients with T4bN1-3M0/TxN3bM0 gastric cancer
por: Wang, Qi-Wei, et al.
Publicado: (2018)

Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma
por: Geng, Zhi-Min, et al.
Publicado: (2019)

Endoscopic retrograde cholangiopancreatography for diagnosing and treating pediatric biliary and pancreatic diseases
por: Qin, Xiu-Min, et al.
Publicado: (2023)

Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases
por: Steinhoff, Heinrich, et al.
Publicado: (2023)

AKR1B10 expression predicts response of gastric cancer to neoadjuvant chemotherapy
por: Ahmed, Syed Minhaj Uddin, et al.
Publicado: (2019)

Efficacy of continuous gastric artery infusion chemotherapy in relieving digestive obstruction in advanced gastric cancer
por: Tang, Rui, et al.
Publicado: (2023)

Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021)

The mechanism of catalysis by type-II NADH:quinone oxidoreductases
por: Blaza, James N., et al.
Publicado: (2017)

Relationship between celiac artery variation and number of lymph nodes dissection in gastric cancer surgery
por: Mu, Guang-Chuan, et al.
Publicado: (2019)

Timing of surgery after neoadjuvant chemotherapy for gastric cancer: Impact on outcomes
por: Liu, Yi, et al.
Publicado: (2018)

Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations
por: den Braver-Sewradj, Shalenie P., et al.
Publicado: (2017)

Differential analysis of lymph node metastasis in histological mixed-type early gastric carcinoma in the mucosa and submucosa
por: Zhong, Qian, et al.
Publicado: (2018)

Is NAD(P)H quinone oxidoreductase 1 a tumor promoter or suppressor in gastric cancer?
por: Cao, Lei, et al.
Publicado: (2023)

Pretreatment serum albumin-to-alkaline phosphatase ratio is an independent prognosticator of survival in patients with metastatic gastric cancer
por: Li, Yu-Ting, et al.
Publicado: (2022)

Serum basic fibroblast growth factor and interleukin-1β predict the effect of first-line chemotherapy in patients with advanced gastric cancer
por: Zheng, Li, et al.
Publicado: (2023)

Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase
por: Niikura, Mamoru, et al.
Publicado: (2017)

Effects of age on survival and morbidity in gastric cancer patients undergoing gastrectomy
por: Fujiwara, Yoshinori, et al.
Publicado: (2017)

Unnecessity of lymph node regression evaluation for predicting gastric adenocarcinoma outcome after neoadjuvant chemotherapy
por: Zhu, Yue-Lu, et al.
Publicado: (2019)

Perioperative chemotherapy for advanced gastric cancer - results from a tertiary-care hospital in Germany
por: Bauer, Katrin, et al.
Publicado: (2020)

Elemene-containing hyperthermic intraperitoneal chemotherapy combined with chemotherapy for elderly patients with peritoneal metastatic advanced gastric cancer
por: Chen, Zhi-Xiong, et al.
Publicado: (2022)

Riboflavin compounds show NAD(P)H dependent quinone oxidoreductase-like quinone reducing activity
por: Nagase, Midori, et al.
Publicado: (2023)

Factors associated with overall survival in early gastric cancer patients who underwent additional surgery after endoscopic submucosal dissection
por: Zheng, Zhi, et al.
Publicado: (2021)

Model established based on blood markers predicts overall survival in patients after radical resection of types II and III adenocarcinoma of the esophagogastric junction
por: Wei, Zhi-Jian, et al.
Publicado: (2022)

Subtotal gastrectomy combined with chemotherapy: An effective therapy for patients with circumscribed Borrmann type IV gastric cancer
por: Huang, Hai-Bo, et al.
Publicado: (2020)

New prognostic model for patients with advanced gastric cancer: Fluoropyrimidine/platinum doublet for first-line chemotherapy
por: Koo, Dong-Hoe, et al.
Publicado: (2021)

Short-term efficacy and influencing factors of conventional chemotherapy combined with irinotecan in patients with advanced gastric cancer
por: Wang, Jun-Ping, et al.
Publicado: (2023)

Novel management indications for conservative treatment of chylous ascites after gastric cancer surgery
por: Kong, Peng-Fei, et al.
Publicado: (2022)

(18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma
por: Li, Xiao-Feng, et al.
Publicado: (2016)

Nomograms for pre- and postoperative prediction of long-term survival among proximal gastric cancer patients: A large-scale, single-center retrospective study
por: Chen, Qi-Yue, et al.
Publicado: (2019)

Clinical benefit and tolerability of adjuvant intraperitoneal chemotherapy in patients who have or have not received neoadjuvant chemotherapy for advanced ovarian cancer
por: Meghal, Trishala, et al.
Publicado: (2019)

Cancer Cell Sensitivity to Redox-Cycling Quinones is Influenced by NAD(P)H: Quinone Oxidoreductase 1 Polymorphism
por: Glorieux, Christophe, et al.
Publicado: (2019)

Short and long-term outcomes between laparoscopic and open total gastrectomy for advanced gastric cancer after neoadjuvant chemotherapy
por: Cui, Hao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3r56kfrq4h24tdpqdsn1cvk8un